Disclaimer: Materials and compounds referenced are for laboratory research use only
Neurologic:Aseptic meningitis, convulsions, peripheral neuritis, ataxia, vertigo, tinnitus, headache
The medication is generally not recommended for individuals with: a personal history of medullary thyroid cancer multiple endocrine neoplasia syndrome type 2 (MEN 2) Although the risk in humans is still being studied, healthcare providers typically evaluate thyroid history before prescribing the medication
GLP-1 receptor agonists, including semaglutide, have also been associated with an increased risk of gallbladder disease, including cholelithiasis (gallstones) and cholecystitis (gallbladder inflammation)
But their broader impact on the clinical trials ecosystem may still be unfolding